FXR1 and cancer: As most RBPs undergo post-translational modifications (PTM) such as phosphorylation, acetylation, methylation, and sumoylation to regulate gene expression in cancer cells (18), here, we set out to study the impact of PTM on FXR1 and its regulatory effects on its RNA targets.